Clinical Trial Update: Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial results for the combination of oxaliplatin and irinotecan in patients with metastatic gastrointestinal cancers, including anal and colorectal canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Colorectal Cancer
• Esophageal Cancer
• Extrahepatic Bile Duct Cancer
• Gallbladder Cancer
• Gastric Cancer
• Liver Cancer
• Pancreatic Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Anal Cancer, Colorectal Cancer | Phase 1 | Status: COMPLETED